Access the full text.
Sign up today, get DeepDyve free for 14 days.
Mónica Faria, M. Pinho (2020)
Challenges of reducing protein-bound uremic toxin levels in chronic kidney disease and end stage renal disease.Translational research : the journal of laboratory and clinical medicine
Tessa Gryp, R. Vanholder, Mario Vaneechoutte, G. Glorieux (2017)
p-Cresyl SulfateToxins, 9
B. Meijers, B. Bammens, K. Verbeke, P. Evenepoel (2008)
A review of albumin binding in CKD.American journal of kidney diseases : the official journal of the National Kidney Foundation, 51 5
L. Viaene, P. Annaert, H. Loor, Ruben Poesen, P. Evenepoel, B. Meijers (2013)
Albumin is the main plasma binding protein for indoxyl sulfate and p‐cresyl sulfateBiopharmaceutics & Drug Disposition, 34
D. Krieter, A. Hackl, Annie Rodriguez, L. Chenine, H. Moragues, H. Lemke, C. Wanner, B. Canaud (2010)
Protein-bound uraemic toxin removal in haemodialysis and post-dilution haemodiafiltration.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 25 1
T. Niwa (2013)
Removal of Protein-Bound Uraemic Toxins by HaemodialysisBlood Purification, 35
T. Meyer, J. Walther, M. Pagtalunan, Andres Martinez, A. Torkamani, Patrick Fong, Natalie Recht, C. Robertson, T. Hostetter (2005)
The clearance of protein-bound solutes by hemofiltration and hemodiafiltration.Kidney international, 68 2
T. Sirich, F. Luo, Natalie Plummer, T. Hostetter, T. Meyer (2012)
Selectively increasing the clearance of protein-bound uremic solutes.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 27 4
Gillian Sudlow, D. Birkett, D. Wade (1975)
The characterization of two specific drug binding sites on human serum albumin.Molecular pharmacology, 11 6
M. Costigan, C. Callaghan, W. Lindup (1996)
Hypothesis: is accumulation of a furan dicarboxylic acid (3-carboxy-4- methyl-5-propyl-2-furanpropanoic acid) related to the neurological abnormalities in patients with renal failure?Nephron, 73 2
S. Kato, Ken‐ichi Otake, Haoyuan Chen, Isil Akpinar, Cassandra Buru, Timur Islamoglu, R. Snurr, O. Farha (2019)
Zirconium-Based Metal-Organic Frameworks for the Removal of Protein-Bound Uremic Toxin from Human Serum Albumin.Journal of the American Chemical Society, 141 6
Sheldon Leong, T. Sirich (2016)
Indoxyl Sulfate—Review of Toxicity and Therapeutic StrategiesToxins, 8
R. Smet, A. Dhondt, S. Eloot, F. Galli, M. Waterloos, R. Vanholder (2007)
Effect of the super-flux cellulose triacetate dialyser membrane on the removal of non-protein-bound and protein-bound uraemic solutes.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 22 7
Suguru Yamamoto, Toru Ito, Mami Sato, S. Goto, J. Kazama, F. Gejyo, I. Narita (2019)
Adsorption of Protein-Bound Uremic Toxins Using Activated Carbon through Direct Hemoperfusion in vitroBlood Purification, 48
R. Vanholder, R. Smet, G. Glorieux, À. Argilés, U. Baurmeister, P. Brunet, W. Clark, G. Cohen, P. Deyn, R. Deppisch, B. Descamps-Latscha, T. Henle, A. Jörres, H. Lemke, Z. Massy, J. Passlick–Deetjen, Mariano Rodriguez, B. Stegmayr, P. Stenvinkel, C. Tetta, C. Wanner, W. Zidek (2003)
Review on uremic toxins: classification, concentration, and interindividual variability.Kidney international, 63 5
Gabriella Fanali, A. Masi, V. Trezza, M. Marino, M. Fasano, P. Ascenzi (2012)
Human serum albumin: from bench to bedside.Molecular aspects of medicine, 33 3
D. Cao, K. Heard, M. Foran, A. Koyfman (2015)
Intravenous lipid emulsion in the emergency department: a systematic review of recent literature.The Journal of emergency medicine, 48 3
D. Krieter, E. Devine, Thomas Körner, M. Rüth, C. Wanner, Manuelle Raine, J. Jankowski, H. Lemke (2017)
Haemodiafiltration at increased plasma ionic strength for improved protein‐bound toxin removalActa Physiologica, 219
M. Madero, Karla Cano, Israel Campos, Xia Tao, Vaibhav Maheshwari, Jillian Brown, Beatriz Cornejo, G. Handelman, S. Thijssen, P. Kotanko (2019)
Removal of Protein-Bound Uremic Toxins during Hemodialysis Using a Binding Competitor.Clinical journal of the American Society of Nephrology : CJASN, 14 3
Suguru Yamamoto, Mami Sato, Yoko Sato, Takuya Wakamatsu, Yoshimitsu Takahashi, Akira Iguchi, K. Omori, Yasushi Suzuki, I. Ei, Y. Kaneko, S. Goto, J. Kazama, F. Gejyo, I. Narita (2018)
Adsorption of Protein‐Bound Uremic Toxins Through Direct Hemoperfusion With Hexadecyl‐Immobilized Cellulose Beads in Patients Undergoing HemodialysisArtificial Organs, 42
Jingyu Li, Lulu Han, Jian Xie, Shuxin Liu, Lingyun Jia (2020)
Multi-sites polycyclodextrin adsorbents for removal of protein-bound uremic toxins combining with hemodialysis.Carbohydrate polymers, 247
Nida Zaidi, M. Ajmal, G. Rabbani, Ejaz Ahmad, R. Khan (2013)
A Comprehensive Insight into Binding of Hippuric Acid to Human Serum Albumin: A Study to Uncover Its Impaired Elimination through HemodialysisPLoS ONE, 8
Vaibhav Maheshwari, S. Thijssen, Xia Tao, Doris Fuertinger, F. Kappel, P. Kotanko (2019)
In silico comparison of protein-bound uremic toxin removal by hemodialysis, hemodiafiltration, membrane adsorption, and binding competitionScientific Reports, 9
T. Cornelis, S. Eloot, R. Vanholder, G. Glorieux, F. Sande, J. Scheijen, K. Leunissen, J. Kooman, C. Schalkwijk (2015)
Protein-bound uraemic toxins, dicarbonyl stress and advanced glycation end products in conventional and extended haemodialysis and haemodiafiltration.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 30 8
R. Vanholder, E. Schepers, A. Pletinck, E. Nagler, G. Glorieux (2014)
The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review.Journal of the American Society of Nephrology : JASN, 25 9
O. Lutz, T. Lavé, A. Frey, Z. Meraihi, A. Bach (1989)
Activities of lipoprotein lipase and hepatic lipase on long- and medium-chain triglyceride emulsions used in parenteral nutrition.Metabolism: clinical and experimental, 38 6
W. Biesen, S. Eloot (2019)
Enhanced Removal of Protein-Bound Uremic Toxins Using Displacers: Road to Success?Clinical journal of the American Society of Nephrology : CJASN, 14 3
J. Patzer (2006)
Principles of Bound Solute DialysisTherapeutic Apheresis and Dialysis, 10
E. Snauwaert, W. Biesen, A. Raes, G. Glorieux, J. Walle, S. Roels, R. Vanholder, V. Askiti, K. Ažukaitis, A. Bayazıt, N. Canpolat, M. Fischbach, Krid Saoussen, M. Litwin, L. Obrycki, F. Paglialonga, B. Ranchin, C. Samaille, F. Schaefer, C. Schmitt, B. Spasojević, C. Stefanidis, R. Shroff, S. Eloot (2020)
Haemodiafiltration does not lower protein-bound uraemic toxin levels compared with haemodialysis in a paediatric population.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
M. Tijink, M. Wester, G. Glorieux, K. Gerritsen, Junfen Sun, P. Swart, Z. Borneman, Matthias Wessling, R. Vanholder, J. Joles, D. Stamatialis (2013)
Mixed matrix hollow fiber membranes for removal of protein-bound toxins from human plasma.Biomaterials, 34 32
R. Fagugli, R. Smet, U. Buoncristiani, N. Lameire, R. Vanholder (2002)
Behavior of non-protein-bound and protein-bound uremic solutes during daily hemodialysis.American journal of kidney diseases : the official journal of the National Kidney Foundation, 40 2
R. Nelson, M. Mundi, Danielle Vlazny, Almira Smailovic, K. Muthusamy, Jaime Almandoz, E. Singh, M. Jensen, J. Miles (2013)
Kinetics of Saturated, Monounsaturated, and Polyunsaturated Fatty Acids in HumansDiabetes, 62
Hunter Cuchiaro, Jonathan Thai, Nick Schaffner, Robert Tuttle, Melissa Reynolds (2020)
Exploring the Parameter Space of p-Cresyl Sulfate Adsorption in Metal-Organic Frameworks.ACS applied materials & interfaces
L. Koppe, V. Poitout (2016)
CMPF: A Biomarker for Type 2 Diabetes Mellitus Progression?Trends in Endocrinology & Metabolism, 27
Yuanyuan Shi, Yumei Zhang, Huajun Tian, Yifeng Wang, Yue-ming Shen, Qiu-yu Zhu, F. Ding (2019)
Improved dialytic removal of protein-bound uremic toxins by intravenous lipid emulsion in chronic kidney disease rats.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Jianping Li, Yingyi Wang, Xuejun Xu, Wenjuan Cao, Zhiqiang Shen, Nan Wang, J. Leng, Ning Zou, E. Shang, Zhen-hua Zhu, Jianming Guo, J. Duan (2019)
Improved dialysis removal of protein-bound uremic toxins by salvianolic acids.Phytomedicine : international journal of phytotherapy and phytopharmacology, 57
D. Hiller, G. Gregorio, Kemba Kelly, Richard Ripper, Lucas Edelman, Redouane Boumendjel, K. Drasner, G. Weinberg (2009)
Safety of High Volume Lipid Emulsion InfusionRegional Anesthesia & Pain Medicine, 35
F. Luo, Kajal Patel, Ilian Marquez, Natalie Plummer, T. Hostetter, T. Meyer (2009)
Effect of increasing dialyzer mass transfer area coefficient and dialysate flow on clearance of protein-bound solutes: a pilot crossover trial.American journal of kidney diseases : the official journal of the National Kidney Foundation, 53 6
T. Meyer, J. Peattie, Jared Miller, D. Dinh, Natalie Recht, J. Walther, T. Hostetter (2007)
Increasing the clearance of protein-bound solutes by addition of a sorbent to the dialysate.Journal of the American Society of Nephrology : JASN, 18 3
C. Basile, P. Libutti, Anna Turo, F. Casino, L. Vernaglione, S. Tundo, Pasquale Maselli, Edy Nicolò, E. Ceci, A. Teutonico, C. Lomonte (2011)
Removal of uraemic retention solutes in standard bicarbonate haemodialysis and long-hour slow-flow bicarbonate haemodialysis.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 26 4
K. Prentice, Lemieux Luu, E. Allister, Y. Liu, Lucy Jun, K. Sloop, A. Hardy, Li Wei, W. Jia, I. Fantus, D. Sweet, G. Sweeney, R. Retnakaran, F. Dai, M. Wheeler (2014)
The furan fatty acid metabolite CMPF is elevated in diabetes and induces β cell dysfunction.Cell metabolism, 19 4
Yuanyuan Shi, Yifeng Wang, Shuai Ma, Tingyan Liu, Huajun Tian, Qiu-yu Zhu, Wenji Wang, Yulin Li, F. Ding (2018)
Increasing the removal of protein-bound uremic toxins by liposome-supported hemodialysis.Artificial organs, 43 5
Toshiaki Sakai, A. Takadate, Masaki Otagiri (1995)
Characterization of binding site of uremic toxins on human serum albumin.Biological & pharmaceutical bulletin, 18 12
Yuanyuan Shi, Huajun Tian, Yifeng Wang, Yue-ming Shen, Qiu-yu Zhu, F. Ding (2018)
Effect of Ionic Strength, pH and Chemical Displacers on the Percentage Protein Binding of Protein-Bound Uremic ToxinsBlood Purification, 47
Olivier Deltombe, W. Biesen, G. Glorieux, Z. Massy, A. Dhondt, S. Eloot (2015)
Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during HemodialysisToxins, 7
N. Florens, Dan Yi, L. Juillard, C. Soulage (2018)
Using binding competitors of albumin to promote the removal of protein-bound uremic toxins in hemodialysis: Hope or pipe dream?Biochimie, 144
Flore Duranton, G. Cohen, R. Smet, Mariano Rodriguez, J. Jankowski, R. Vanholder, À. Argilés (2012)
Normal and pathologic concentrations of uremic toxins.Journal of the American Society of Nephrology : JASN, 23 7
Laetitia Dou, M. Sallée, C. Cérini, S. Poitevin, B. Gondouin, N. Jourde-Chiche, K. Fallague, P. Brunet, R. Calaf, B. Dussol, B. Mallet, F. Dignat-George, S. Burtey (2015)
The cardiovascular effect of the uremic solute indole-3 acetic acid.Journal of the American Society of Nephrology : JASN, 26 4
N. Meert, S. Eloot, E. Schepers, H. Lemke, A. Dhondt, G. Glorieux, M. Landschoot, M. Waterloos, R. Vanholder (2011)
Comparison of removal capacity of two consecutive generations of high-flux dialysers during different treatment modalities.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 26 8
F. Brettschneider, M. Tölle, M. Giet, J. Passlick–Deetjen, Sonja Steppan, Mirjam Peter, V. Jankowski, A. Krause, Sophie Kühne, W. Zidek, J. Jankowski (2013)
Removal of protein-bound, hydrophobic uremic toxins by a combined fractionated plasma separation and adsorption technique.Artificial organs, 37 4
Falko Böhringer, V. Jankowski, P. Gajjala, W. Zidek, J. Jankowski (2015)
Release of Uremic Retention Solutes from Protein Binding by Hypertonic Predilution HemodiafiltrationASAIO Journal, 61
DB Hiller, G Di Gregorio, K Kelly, R Ripper, L Edelman, R Boumendjel (2010 MarApr)
Safety of high volume lipid emulsion infusion: a first approximation of LD50 in rats, 35
E. Hulme, M. Trevethick (2010)
Ligand binding assays at equilibrium: validation and interpretationBritish Journal of Pharmacology, 161
Xia Tao, S. Thijssen, P. Kotanko, Chih-Hu Ho, M. Henrie, E. Stroup, G. Handelman (2016)
Improved dialytic removal of protein-bound uraemic toxins with use of albumin binding competitors: an in vitro human whole blood studyScientific Reports, 6
Yi-Ting Lin, P. Wu, Hei-Hwa Lee, M. Mubanga, Cheng-Sheng Chen, M. Kuo, Y. Chiu, Po-Lin Kuo, Shang-Jyh Hwang (2019)
Indole-3 acetic acid increased risk of impaired cognitive function in patients receiving hemodialysis.Neurotoxicology, 73
Introduction: Protein-bound uraemic toxins (PBUTs) are poorly removed by conventional dialytic techniques, given their high plasma protein binding, and thus low, free (dialysable) plasma concentration. Here, we evaluated and compared PBUTs removal among conventional haemodialysis (HD), adsorption-based HD, displacement-based HD, and their 2 combinations both in vitro and in vivo. Methods: The removal of PBUTs, including 3-carboxy-4-methyl-5-propyl-2-furan-propanoic acid (CMPF), p-cresyl sulphate (PCS), indoxyl sulphate (IS), indole-3-acetic acid (3-IAA), and hippuric acid, was first evaluated in an in vitro single-pass HD model. Adsorption consisted of adding 40 g/L bovine serum albumin (Alb) to the dialysate and displacement involved infusing fatty acid (FA) mixtures predialyser. Then, uraemic rats were treated with either conventional HD, Alb-based HD, lipid emulsion infusion-based HD or their combination to calculate the reduction ratio (RR), and the total solute removal (TSR) of solutes after 4 h of therapy. Results: In vitro dialysis revealed that FAs infusion prefilter increased the removal of PCS, IS, and 3-IAA 3.23-fold, 3.01-fold, and 2.24-fold, respectively, compared with baseline and increased the fractional removal of CMPF from undetectable at baseline to 14.33 ± 0.24%, with a dialysis efficacy markedly superior to Alb dialysis. In vivo dialysis showed that ω-6 soybean oil-based lipid emulsion administration resulted in higher RRs and more TSRs for PCS, IS, and 3-IAA after 4-h HD than the control, and the corresponding TSR values for PCS and IS were also significantly increased compared to that of Alb dialysis. Finally, the highest dialysis efficacy for highly bound solute removal was always observed with their combination both in vitro and in vivo. Conclusions: The concept of combined displacement- and adsorption-based dialysis may open up new avenues and possibilities in the field of dialysis to further enhance PBUTs removal in end-stage renal disease.
Blood Purification – Karger
Published: Jun 1, 2022
Keywords: End-stage renal disease; Protein-bound uraemic toxins; Haemodialysis; Adsorption technology; Displacer augmented dialysis technique
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.